26.12.2014 Views

Clinical Biochemistry of Domestic Animals (Sixth Edition) - UMK ...

Clinical Biochemistry of Domestic Animals (Sixth Edition) - UMK ...

Clinical Biochemistry of Domestic Animals (Sixth Edition) - UMK ...

SHOW MORE
SHOW LESS

Create successful ePaper yourself

Turn your PDF publications into a flip-book with our unique Google optimized e-Paper software.

726<br />

Chapter | 23 Vitamins<br />

V . VITAMIN-LIKE COMPOUNDS<br />

A . Lipotropic Factors<br />

Nutritional requirements exist for a number <strong>of</strong> compounds<br />

at specific periods in development, particularly neonatal<br />

development, and periods <strong>of</strong> rapid growth. These compounds<br />

typically perform specialized transport functions<br />

particularly in relation to fatty acids. Apart from specific<br />

amino acids such as methionine and glycine in feathered<br />

animals, examples include choline, inositol, and carnitine.<br />

1 . Choline<br />

Choline is particularly noteworthy because it plays a key<br />

role in methyl group metabolism, carcinogenesis, and<br />

lipid transport as a component <strong>of</strong> lecithin ( Garrow, 2007 ).<br />

Choline is normally produced in sufficient amounts; however,<br />

in young growing animals, a positive growth response<br />

can occur upon addition <strong>of</strong> choline, commercially available<br />

as trimethyl hydroxyethyl ammonium chloride or as<br />

the bitartrate. Choline is generally added to diets to reduce<br />

the need for activated methyl groups supplied by methionine.<br />

It is more economical to add choline for these methyl<br />

groups than to add methionine.<br />

Choline is one <strong>of</strong> the precursors <strong>of</strong> acetylcholine.<br />

Choline is also a component <strong>of</strong> sphingomyelin and lecithin.<br />

Formation <strong>of</strong> betaine from choline provides important<br />

sources <strong>of</strong> labile methyl groups for transmethylation reactions.<br />

Choline can also be synthesized de novo from ethanolamine,<br />

when methionine or dimethylcysteine, or betaine is<br />

in adequate supply. The most abundant source <strong>of</strong> choline in<br />

the diet is lecithin. The primary sign <strong>of</strong> choline deficiency is<br />

fatty liver. In monkeys, dogs, cats, and rats, it has also been<br />

shown that prolonged choline deficiency results in cirrhosis.<br />

In mice and rats, prolonged deficiency ultimately results in<br />

hepatocellular cancer, a unique example <strong>of</strong> nutrition deficiency<br />

resulting in neoplasm. Five hundred to 1000 mg <strong>of</strong><br />

choline are <strong>of</strong>ten added per kilogram <strong>of</strong> diet ( Garrow, 2007 ).<br />

2 . Inositol<br />

Inositol is also a component <strong>of</strong> phospholipids and, similar<br />

to choline, results in a fatty liver, if insufficient in supply<br />

( Holub, 1986, 1992 ). Inositol is synthesized from glucose-<br />

6-phosphate after cyclization. In some animals, particularly<br />

gerbils and hamsters, there is a nutritional need for<br />

inositol when they are given diets containing coconut oil.<br />

Myoinositol is plentiful in foodstuffs. The estimated daily<br />

intake for large animals can be as high as 1 or 2g per day.<br />

Inositol is particularly important in cellular signal transduction<br />

and phospholipid assembly. Plasma levels <strong>of</strong> inositol are<br />

increased during renal disease and nephrectomy. The presence<br />

<strong>of</strong> myoinositol hexabisphosphate (InsP6) in biological<br />

fluids (blood, urine, saliva, interstitial fluid) <strong>of</strong> animals has<br />

been clearly demonstrated. The existence <strong>of</strong> intracellular<br />

InsP6 in mammalian cells has also been established. A<br />

relationship between InsP6 ingestion and the InsP6 distribution<br />

in various tissues exists. Whereas intracellular inositol<br />

depends on endogenous synthesis, depletion <strong>of</strong> extracellular<br />

InsP6 occurs at high rates when InsP6-poor diets are consumed.<br />

Consequently, there are probably health benefits that<br />

are linked to dietary inositol and InsP6 intake. The suggestion<br />

that inositol is important in young animals came from<br />

studies carried out throughout the 1970s and 1980s. In particular,<br />

it was noted that female gerbils fed a diet containing<br />

high coconut oil (relatively saturated) develop an intestinal<br />

lipodystrophy that is not seen in animals fed a diet containing<br />

20% safflower oil (relatively unsaturated) or a diet <strong>of</strong><br />

20% coconut oil supplemented with 0.1% inositol. The level<br />

<strong>of</strong> inositol in the intestinal tissue <strong>of</strong> animals fed the coconut<br />

oil diet not supplemented with inositol has been shown to<br />

decrease. Clearance <strong>of</strong> lipid (i.e., resolution <strong>of</strong> the lipodystrophy)<br />

was dependent on inositol ( Holub, 1986, 1992 ).<br />

3 . Carnitine<br />

Oxidation <strong>of</strong> fatty acids requires their transportation from the<br />

cytosol into the mitochondrial matrix where they undergo<br />

β -oxidation. Carnitine plays a major role in this transport<br />

process by accepting activated fatty acids at the outer<br />

mitochondrial membrane. Carnitine comes both from the<br />

diet and synthesis from lysine by a process that is ascorbic<br />

acid dependent. These steps are not carried out efficiently<br />

in some newborns. Given the importance <strong>of</strong> carnitine to<br />

β -oxidation <strong>of</strong> long-chain fatty acids, carnitine deficiency<br />

can have pr<strong>of</strong>ound effects on lipid utilization. An inherited<br />

carnitine deficiency has been recognized in some dogs such<br />

as the boxer ( Keene, 1991 ; Keene et al., 1991 ; Kittleson<br />

et al., 1997 ; Mc Entee et al., 2001 ). Moreover, American<br />

cocker spaniels that are taurine deficient have been shown<br />

to be responsive to a combination <strong>of</strong> taurine and carnitine<br />

supplementation ( Kittleson et al., 1997 ).<br />

Meats and dairy products in contrast to plant foods are<br />

good sources <strong>of</strong> carnitine. Cereal grains besides being low<br />

in carnitine are also generally low in the precursors <strong>of</strong> carnitine:<br />

lysine and methionine. Drugs, such as mildronate<br />

(3-(2, 2, 2,-trimethylhydrazinium) propionate) can also lower<br />

carnitine levels and inhibit synthesis. Mildronate is a<br />

butyrobetaine analogue that is known to inhibit gammabutyrobetaine<br />

hydroxylase, the enzyme catalyzing the<br />

last step <strong>of</strong> carnitine biosynthesis. In humans, mildronate<br />

is used to ameliorate cardiac function during ischemia by<br />

modulating myocardial fatty acid oxidation to the more<br />

favorable glucose oxidation. When given to pregnant animals,<br />

carnitine levels increase in the milk. Correspondingly,<br />

an increase in triglyceride levels is observed in liver, heart,<br />

and muscle <strong>of</strong> mildronate pups (i.e., biochemical modifications<br />

compatible with a carnitine deficiency status).

Hooray! Your file is uploaded and ready to be published.

Saved successfully!

Ooh no, something went wrong!